379 GENES FOUND

Show / hide columns »

XML | RDF | TAB | « prev | Page of 8 | next »

Gene

 

 

Gene description

x

 

 

Protein class

x

 

 

 

 

Tissue

Cell

Cancer

 

 

 

 

 

 

Subcellular location

x

RNA tissue category

x

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

HTR3D5-hydroxytryptamine (serotonin) receptor 3D, ionotropicPredicted membrane proteins
Transporters
Not detected
HVCN1Hydrogen voltage gated channel 1Predicted intracellular proteins
Predicted membrane proteins
Transporters
Mixed
IPO11Importin 11Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
Transporters
Nucleus
Nucleoli fibrillar center
Expressed in all
IPO13Importin 13Predicted intracellular proteins
Transporters
Expressed in all
IPO4Importin 4Predicted intracellular proteins
Transporters
CytosolTissue enhanced
IPO5Importin 5Plasma proteins
Predicted intracellular proteins
Transporters
Nucleoplasm
Cytosol
Expressed in all
IPO7Importin 7Cancer-related genes
Plasma proteins
Predicted intracellular proteins
Transporters
Nucleoplasm
Cytosol
Expressed in all
IPO8Importin 8Predicted intracellular proteins
Transporters
NucleusExpressed in all
IPO9Importin 9Predicted intracellular proteins
Predicted secreted proteins
Transporters
Vesicles
Cytosol
Expressed in all
ITPR1Inositol 1,4,5-trisphosphate receptor, type 1Disease related genes
Plasma proteins
Potential drug targets
Predicted membrane proteins
Transporters
VesiclesTissue enhanced
KCNA2Potassium channel, voltage gated shaker related subfamily A, member 2Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enriched
KCNA3Potassium channel, voltage gated shaker related subfamily A, member 3FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Mixed
KCNA5Potassium channel, voltage gated shaker related subfamily A, member 5Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCNB1Potassium channel, voltage gated Shab related subfamily B, member 1Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCNC3Potassium channel, voltage gated Shaw related subfamily C, member 3Disease related genes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCND2Potassium channel, voltage gated Shal related subfamily D, member 2Disease related genes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCND3Potassium channel, voltage gated Shal related subfamily D, member 3Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Mixed
KCNF1Potassium channel, voltage gated modifier subfamily F, member 1Plasma proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Golgi apparatusTissue enriched
KCNH1Potassium channel, voltage gated eag related subfamily H, member 1Disease related genes
Potential drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
VesiclesTissue enriched
KCNH2Potassium channel, voltage gated eag related subfamily H, member 2Disease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCNH3Potassium channel, voltage gated eag related subfamily H, member 3Predicted membrane proteins
Transporters
Voltage-gated ion channels
Nucleus
Mitochondria
Group enriched
KCNJ1Potassium channel, inwardly rectifying subfamily J, member 1Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enriched
KCNJ13Potassium channel, inwardly rectifying subfamily J, member 13Disease related genes
Potential drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Group enriched
KCNJ16Potassium channel, inwardly rectifying subfamily J, member 16Predicted intracellular proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
VesiclesGroup enriched
KCNJ2Potassium channel, inwardly rectifying subfamily J, member 2Disease related genes
Potential drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCNJ3Potassium channel, inwardly rectifying subfamily J, member 3Plasma proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCNJ5Potassium channel, inwardly rectifying subfamily J, member 5Cancer-related genes
Disease related genes
Potential drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCNJ6Potassium channel, inwardly rectifying subfamily J, member 6Disease related genes
Potential drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enriched
KCNJ8Potassium channel, inwardly rectifying subfamily J, member 8Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Mixed
KCNK15Potassium channel, two pore domain subfamily K, member 15Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCNK16Potassium channel, two pore domain subfamily K, member 16Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCNK17Potassium channel, two pore domain subfamily K, member 17Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCNK3Potassium channel, two pore domain subfamily K, member 3Disease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCNK5Potassium channel, two pore domain subfamily K, member 5Predicted membrane proteins
Transporters
Voltage-gated ion channels
NucleusTissue enhanced
KCNK6Potassium channel, two pore domain subfamily K, member 6Predicted membrane proteins
Transporters
Voltage-gated ion channels
Plasma membrane
Actin filaments
Cytosol
Mixed
KCNK9Potassium channel, two pore domain subfamily K, member 9Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Group enriched
KCNN2Potassium channel, calcium activated intermediate/small conductance subfamily N alpha, member 2Plasma proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Nucleoplasm
Cytosol
Tissue enhanced
KCNN4Potassium channel, calcium activated intermediate/small conductance subfamily N alpha, member 4Disease related genes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCNQ1Potassium channel, voltage gated KQT-like subfamily Q, member 1Disease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCNQ2Potassium channel, voltage gated KQT-like subfamily Q, member 2Disease related genes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Endoplasmic reticulumTissue enriched
KCNQ3Potassium channel, voltage gated KQT-like subfamily Q, member 3Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enriched
KCNQ4Potassium channel, voltage gated KQT-like subfamily Q, member 4Disease related genes
Potential drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Mixed
KCNS1Potassium voltage-gated channel, modifier subfamily S, member 1Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCNS2Potassium voltage-gated channel, modifier subfamily S, member 2Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCNS3Potassium voltage-gated channel, modifier subfamily S, member 3Predicted intracellular proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Golgi apparatus
Plasma membrane
Cytosol
Tissue enhanced
KCNT1Potassium channel, sodium activated subfamily T, member 1Disease related genes
Potential drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Group enriched
KCNT2Potassium channel, sodium activated subfamily T, member 2Predicted intracellular proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
VesiclesTissue enhanced
KPNA1Karyopherin alpha 1 (importin alpha 5)Predicted intracellular proteins
Transporters
Nucleus
Cytosol
Expressed in all
KPNA2Karyopherin alpha 2 (RAG cohort 1, importin alpha 1)Plasma proteins
Predicted intracellular proteins
Transporters
Nucleoplasm
Cytosol
Expressed in all
KPNA3Karyopherin alpha 3 (importin alpha 4)Predicted intracellular proteins
Transporters
Nucleoplasm
Cytosol
Expressed in all

« prev | Page of 8 | next »